Ingredion IncINGR
Price$94.91Intrinsic value$102.248% above price

Qualitative Analysis

Business overview

Business Overview

Ingredion Incorporated (NYSE: INGR) is a leading global provider of ingredient solutions, turning grains, fruits, vegetables, and other plant-based materials into value-added ingredients for the food, beverage, animal nutrition, brewing, and industrial markets. Headquartered in Westchester, Illinois, the company operates in key segments including Texture & Healthful Solutions, Food & Industrial Ingredients–LATAM, and Food & Industrial Ingredients–U.S./Canada. Ingredion serves customers in more than 120 countries, utilizing its global network of Ingredion Idea Labsu0000 innovation centers to co-create customized solutions that address shifting consumer preferences toward clean-label, plant-based, and healthy options.

Research as of 19 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Enterprise ProductivityEfficiency

A multi-year journey focused on driving operational efficiencies, sharpening customer mix priorities, and eliminating waste throughout the organization by leveraging continuous improvement, lean manufacturing, and artificial intelligence for predictive formulation.

Expected impact: Expected to contribute over 1 percentage point of operating income growth by 2028.

Sign in / Sign up to read more
InvestmentNot specified
TimelineMulti-year journey with targets extending through 2028
Indianapolis Starch ModernizationInnovation

A major capital upgrade project at the flagship Indianapolis facility to modernize specialty starch and nutrient-carrier production.

Expected impact: Reduces modified starch production costs through more efficient product flows and debottlenecking, while expanding capacity to support clean-label texture solutions growth.

Sign in / Sign up to read more
Investment$100 million
TimelineCompleted in Q4 2025
Belcamp Blending Center ExpansionExpansion

Expansion of the blending center of expertise in Belcamp, Maryland, to support customized solutions across clean label, plant-based protein, fiber fortification, and sugar reduction.

Expected impact: Increases customized solutions revenue potential by approximately $30 million annually.

Sign in / Sign up to read more
InvestmentNot specified
TimelineCompleted in late 2025

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

Tate & Lyle PLC$3.6B
Announced 8 Jun 2026

To create a scaled global leader in specialty ingredient solutions by combining complementary portfolios across texturants, sugar reduction, mouthfeel, sweetening, and fortification, while expanding geographic reach in North America, Europe, and emerging markets.

Financial impact: Expected to be adjusted EPS accretive in the first year post-completion and deliver approximately $130 million in annual run-rate net cost synergies by 2030.

Sign in / Sign up to read more
Benicaros (Asset Acquisition from NutriLeads B.V.)
Announced 2 Jun 2026

Acquisition of the patented prebiotic fiber Benicaros (derived from upcycled carrot pomace) to expand Ingredion's functional ingredients and health/wellness portfolio with a highly differentiated, clean-label, and sustainable solution.

Financial impact: Terms of the transaction were not disclosed.

Sign in / Sign up to read more

Strategic Partnerships

Sanstar LimitedJoint Venture & Equity Investment

Establishes a local platform for vertically integrated, science-led specialty ingredients and solutions in India, which is one of the fastest-growing specialty starch and functional ingredients markets in the Asia-Pacific region.

Terms: Ingredion will form a joint venture with Sanstar and make a 9% equity investment in the company, alongside commissioning a greenfield construction project to manufacture specialty pharmaceutical and other ingredient products.

Sign in / Sign up to read more
Sources: 1
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.